Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
06/20/2025 | CALL | $195.00 | 1,561 | +1,500 | +2,459.02% |
06/20/2025 | PUT | $195.00 | 1,500 | +1,500 | |
06/20/2025 | CALL | $210.00 | 8,958 | +302 | +3.49% |
05/02/2025 | CALL | $197.50 | 683 | +265 | +63.40% |
05/02/2025 | PUT | $190.00 | 542 | +238 | +78.29% |
08/15/2025 | PUT | $195.00 | 1,438 | +203 | +16.44% |
05/02/2025 | CALL | $192.50 | 717 | -23 | -3.11% |
05/16/2025 | CALL | $200.00 | 9,431 | -42 | -0.44% |
05/02/2025 | CALL | $190.00 | 371 | -73 | -16.44% |
05/16/2025 | CALL | $175.00 | 2,997 | -76 | -2.47% |
06/20/2025 | PUT | $150.00 | 4,374 | -417 | -8.70% |
05/16/2025 | CALL | $182.50 | 265 | -515 | -66.03% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.05% | 53.76M | 7.26B |
Vanguard 500 Index Fund | 2.32% | 40.88M | 5.52B |
Fidelity 500 Index Fund | 1.10% | 19.39M | 2.62B |
SPDR S&P 500 ETF Trust | 1.09% | 19.15M | 2.58B |
American Mutual Fund Inc | 1.00% | 17.6M | 2.38B |
iShares Core S&P 500 ETF | 0.89% | 15.78M | 2.13B |
Vanguard Index-Value Index Fund | 0.87% | 15.28M | 2.06B |
Capital Income Builder, Inc. | 0.84% | 14.87M | 2.01B |
Select Sector SPDR Fund-Health Care | 0.81% | 14.36M | 1.94B |
Washington Mutual Investors Fund | 0.75% | 13.22M | 1.78B |
3 Dividend Stocks to Buy and Hold for the Next Decade
04/28 07:47 am
The Motley Fool
Read moreShould Investors Be Worried About Dividend King AbbVie?
04/28 04:42 am
The Motley Fool
Read more4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
04/26 06:05 pm
The Motley Fool
Read moreWhy AbbVie Stock Topped the Market Today
04/25 05:17 pm
The Motley Fool
Read moreWhy Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
04/22 05:37 pm
The Motley Fool
Read moreIs AbbVie Stock a Buy?
04/20 08:15 am
The Motley Fool
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
04/18 05:12 pm
GlobeNewswire Inc.
Read moreAtopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market
04/18 04:26 am
GlobeNewswire Inc.
Read moreROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
04/14 05:33 pm
GlobeNewswire Inc.
Read moreMale Hypogonadism Market Forecast Report and Company Analysis 2025-2034 Featuring AbbVie, Bayer, Eli Lilly, Endo, Ferring, Perrigo, Pfizer, Sanofi, Teva, and Viatris
04/10 10:00 am
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read more2 Top Dividend Stocks That Could Set You Up for Life
04/09 07:00 am
The Motley Fool
Read moreDr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
04/09 05:44 am
The Motley Fool
Read moreOphthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities
04/08 04:52 am
GlobeNewswire Inc.
Read moreGlobal Cosmeceuticals Market Size to Reach USD 182.17 Bn by 2032, at a CAGR of 9.6%, says Coherent Market Insights
04/08 12:50 am
GlobeNewswire Inc.
Read more3 Dividend Stocks to Buy and Hold for the Next Decade
04/06 06:44 am
The Motley Fool
Read more2 Dividend Stocks to Buy Hand Over Fist in April
04/05 08:30 am
The Motley Fool
Read moreTrump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More
04/03 12:30 pm
Benzinga
Read morePersonalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases
04/02 04:52 am
GlobeNewswire Inc.
Read moreWant $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
03/31 04:53 am
The Motley Fool
Read moreGlobal Autoimmune Disease Therapeutics Market to reach USD 226,194.0 Million by 2035 Amid Rising Prevalence and Advancements in Biologic Therapies | Future Market Insights, Inc.
03/23 08:30 pm
GlobeNewswire Inc.
Read moreGenmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
03/21 11:29 pm
GlobeNewswire Inc.
Read moreAbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
03/17 02:02 pm
Benzinga
Read more5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond
03/17 07:45 am
The Motley Fool
Read more1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction
03/16 06:19 pm
The Motley Fool
Read more3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
03/14 05:51 am
The Motley Fool
Read moreComplement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030
03/12 11:50 am
GlobeNewswire Inc.
Read moreXilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results
03/11 07:30 am
GlobeNewswire Inc.
Read moreMixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas
03/10 04:53 pm
The Motley Fool
Read moreIs the Vanguard High Dividend Yield ETF the Smartest Investment You Can Make Today?
03/10 06:11 am
The Motley Fool
Read moreIs the SPDR S&P 500 ETF Trust the Smartest Investment You Can Make Today?
03/09 12:10 pm
The Motley Fool
Read more3 Cheap Stocks to Buy With Your Tax Refund Check
03/07 06:30 am
The Motley Fool
Read moreAbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race
03/03 03:07 pm
Benzinga
Read moreOPZELURA Continues to Revolutionize Dermatology Market with Strong Market Uptake | DelveInsight
02/28 02:00 pm
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
02/27 06:47 am
The Motley Fool
Read moreNon-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight
02/26 02:00 pm
GlobeNewswire Inc.
Read moreDURYSTA’s Market Potential Across the 7MM is Set to Soar During the Study Period (2020–2034) as a Game-Changer in Ophthalmic Care | DelveInsight
02/26 02:00 pm
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read moreBESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
02/20 02:00 pm
GlobeNewswire Inc.
Read moreAntibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight
02/20 02:00 pm
GlobeNewswire Inc.
Read more2 Magnificent Dividend Growth Stocks to Load Up On Right Now
02/20 06:30 am
The Motley Fool
Read more4 Stocks and 1 Exchange-Traded Fund (ETF) I Can't Stop Buying
02/19 11:42 am
The Motley Fool
Read moreWant Decades of Passive Income? Buy This ETF and Hold It Forever.
02/18 07:15 am
The Motley Fool
Read moreIs AbbVie Stock a Buy Now?
02/15 05:55 am
The Motley Fool
Read moreAlpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight
02/13 02:00 pm
GlobeNewswire Inc.
Read more3 Stocks That Missed on Earnings, but Are Set to Rebound Next Quarter
02/11 08:18 am
Investing.com
Read more3 Fabulous Dividend Stocks to Buy in February
02/09 03:30 pm
The Motley Fool
Read more3 Dividend Stocks to Double Up on Right Now
02/09 06:43 am
The Motley Fool
Read moreThese 2 Dividend Stocks Are Absolute Bargains Right Now
02/08 09:30 am
The Motley Fool
Read more